Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

ClinicalTrials.gov ID: NCT01603277

Public ClinicalTrials.gov record NCT01603277. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Placebo-controlled, Randomized Study to Evaluate the Safety, Tolerability, and Efficacy of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Study identification

NCT ID
NCT01603277
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Humanigen, Inc.
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Anti-GM-CSF Monoclonal Antibody 400mg Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
16 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012
Primary completion
Jun 30, 2013
Completion
Dec 31, 2013
Last update posted
Feb 1, 2015

2012 – 2014

United States locations

U.S. sites
33
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Not listed Birmingham Alabama 35216
Not listed Fullerton California 92835
Not listed Granada Hills California 91344
Not listed Los Angeles California 90025
Not listed Rancho Mirage California 92270
Not listed Sacramento California 95819
Not listed San Jose California 95117
Not listed Centennial Colorado 80112
Not listed Colorado Springs Colorado 80907
Not listed Denver Colorado 80206
Not listed Waterbury Connecticut 06708
Not listed Miami Florida 33136
Not listed Miami Florida 33171
Not listed Tampa Florida 33613
Not listed Winter Park Florida 32789
Not listed Duluth Georgia 30096
Not listed Lawrenceville Georgia 30046
Not listed Savannah Georgia 31405
Not listed Lexington Kentucky 40536
Not listed Ann Arbor Michigan 48109
Not listed St Louis Missouri 63110
Not listed Reno Nevada 89502
Not listed Summit New Jersey 07901
Not listed Winston-Salem North Carolina 27157
Not listed Oklahoma City Oklahoma 73120
Not listed Oklahoma City Oklahoma 73131
Not listed Warwick Rhode Island 02886
Not listed Charleston South Carolina 29407
Not listed Charleston South Carolina 29425
Not listed Greenville South Carolina 29615
Not listed Arlington Texas 76012
Not listed Sugarland Texas 77479
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01603277, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2015 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01603277 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →